The diabetes medical device market encompasses many different categories and sub-categories, and the disease continues to be a major problem. Even though uncertainties continue to plague the healthcare system in the U.S., the market should continue to trend upward in the coming years.
iData Research produces diabetes devices market reports that are unmatched in their depth and accuracy, providing healthcare companies of all sizes the necessary intelligence to help them determine their most effective strategies.
“I was impressed with the depth and breadth of information contained in the report.”
-Jordan Fein, Marketing Research Analyst
“The reports are very useful”
-R&D Team Leader
“Great overall experience with iData Research as a company. The type of research they provide should be part of all new product development efforts.”
-Laszlo Garamszegi, CTO
“iData provides the best-detailed level analysis for segments and sub-segments of any industry reports available.”
-Medical Device Commercialization Strategist
“Great products, outstanding customer service.”
“Most complete data available. Very flexible in providing only the things I needed.”
iData Research has an ever-expanding medical market intelligence library consisting of focused, in-depth, accurate, and exclusive research you will not find anywhere else. Our highly qualified team of industry analysts follow a structured and independent research methodology designed to provide the most valuable return on actionable market data in the world.
Showing 1–12 of 17 results
iData delivers reports on a wide variety of topics, including the insulin market, the insulin pump market and much, much more. Devices we cover include the following:
While there are many opportunities in the insulin pump market, as well as several other diabetes device markets, competition for healthcare funds continues to be fierce. Factors that support continued growth include the prevalence of age-related diseases, demographics and advances in technology. New products are being introduced on a regular basis, and scientific advances continue to progress exponentially.
Growth in the diabetes device market will continue to be driven by these advances, as well as the fact that the disease continues to be prevalent in the U.S. Limiting factors will include downward pressure on prices in areas such as the blood glucose test strip segment, changes in reimbursement, and others.
However, opportunities will also abound in the areas of diabetes treatment and prevention, which, thanks to the introduction of new therapies, look extremely promising.
iData’s diabetes devices market reports are compiled using industry-leading methodology. Our staff members dig deep into the industry, interviewing experts with medical associations as well as relevant company executives, researching economic and epidemiological studies, SEC filings and industry journals, and much more. We provide information on the latest trends and forces that executives and managers use when they need a comprehensive picture of where the market is currently and where it’s headed.
We provide a clear, up-to-date picture of the implications of the trends shaping the market, both in the U.S. and worldwide. Our reports also include in-depth discussion of the major players in the industry, as well as a thorough examination of activity regarding mergers and acquisitions. In addition, we have the tools and knowledge necessary to provide extensive sales forecasts for a wide variety of device categories.
Companies across the healthcare industry turn to iData for the deep research they need to make the most well-informed decisions possible. Our reports have helped established Fortune 500 companies, such as Johnson & Johnson, as well as emerging players alike, giving them the clearest, most actionable picture possible of the marketplace.
If you would like to learn more about our work in the diabetes medical device market or any of the other many areas we cover, please contact iData Research online or give us a call at 1 (866) 964-3282.